Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1297, 2001-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Reviewing the management of HCV infection
Inpharma, Vol. 1, Iss. 1296, 2001-01 ,pp. :
FDA is reviewing safety of omalizumab
Reactions Weekly, Vol. 1, Iss. 1262, 2009-01 ,pp. :
-blockers: reviewing the risks
Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. :